All sponsors

Shanghai Huaota Biopharmaceutical Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS10
PHASE 3 / 2-33
RECRUITING5
READOUTS ≤12 MONTHS1
Open Shanghai Huaota Biopharmaceutical Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
HB0034
NCT06231381
P2RecruitingGeneralized Pustular Psoriasis (GPP)332025-02-13
HB0036
NCT05417321
P1/2RecruitingAdvanced Solid Tumor; NSCLC802025-08-01
HB0052 Injection
NCT06992687
P1/2Enrolling by invitationSolid Tumors302025-09-30
HB0043-HS-0-01
NCT06895499
P1/2RecruitingHidradenitis Suppurativa152026-01-30
HB0043
NCT07449156
P1/2Not yet recruitingAcne Vulgaris212026-10-27
HB0056
NCT07899996
P1/2RecruitingAsthma1602027-08-01
HB0056
NCT07909655
P2Not yet recruitingIdiopathic Pulmonary Fibrosis (IPF)752028-01
Pemetrexed injection
NCT07383116
P3Not yet recruitingNon Squamous Non-small Cell Lung Cancer5002028-04-10
Carboplatin Injection
NCT07360132
P3Not yet recruitingSquamous Non-small Cell Lung Cancer4802028-04-10
HB0025 Injection
NCT07902999
P3RecruitingFirst-line pMMR Endometrial Cancer3332029-04-23